These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 705875

  • 1. Protective effect of murine sarcoma virus-superinfected mouse tumor cells against outgrowth of corresponding noninfected tumor.
    Kuzumaki N, Fenyö EM, Klein E, Klein G.
    Transplantation; 1978 Nov; 26(5):304-7. PubMed ID: 705875
    [Abstract] [Full Text] [Related]

  • 2. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK, Ames RS, McIntire RK, Herberman RB.
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [Abstract] [Full Text] [Related]

  • 3. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.
    Hellström I, Hellström KE, Zeidman L, Bernstein ID, Brown JP.
    Int J Cancer; 1979 Apr 15; 23(4):555-64. PubMed ID: 86527
    [Abstract] [Full Text] [Related]

  • 4. Dissecting the immune response to moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach.
    Milan G, Zambon A, Cavinato M, Zanovello P, Rosato A, Collavo D.
    J Virol; 1999 Mar 15; 73(3):2280-7. PubMed ID: 9971811
    [Abstract] [Full Text] [Related]

  • 5. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D, Ronchese F, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1982 Feb 15; 128(2):774-9. PubMed ID: 6459385
    [No Abstract] [Full Text] [Related]

  • 6. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V, Lahaye T, Horvath C, Zanovello P, Collavo D, Engers HD.
    Eur J Immunol; 1987 Feb 15; 17(2):173-8. PubMed ID: 3030766
    [Abstract] [Full Text] [Related]

  • 7. Tumour-associated transplantation antigens of neoplasms induced by a naturally occurring murine sarcoma virus (FBJ-MSV).
    Jones DB, Moore M.
    Br J Cancer; 1973 Jun 15; 27(6):415-26. PubMed ID: 4516007
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Studies on mouse Moloney virus induced tumours: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibody mediated cytotoxicity.
    Epstein LB, Knight RA.
    Br J Cancer; 1975 May 15; 31(5):499-512. PubMed ID: 50852
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). I. Detection of group and type specific antigens by complement fixation.
    Jones DB, Moore M.
    Br J Cancer; 1974 Jan 15; 29(1):21-30. PubMed ID: 4820943
    [Abstract] [Full Text] [Related]

  • 14. Lack of distinctive surface antigen on cells transformed by murine sarcoma virus.
    Strouk V, Grundner G, Fenyö EM, Lamon E, Skurzak H, Klein G.
    J Exp Med; 1972 Aug 01; 136(2):344-52. PubMed ID: 5043415
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV)-induced tumors and transplanted lymphomas.
    Leclerc JC, Gomard E, Levy JP.
    Int J Cancer; 1972 Nov 01; 10(3):589-601. PubMed ID: 4128690
    [No Abstract] [Full Text] [Related]

  • 17. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.
    Plata F, Cerottini JC, Brunner KT.
    Eur J Immunol; 1975 Apr 01; 5(4):227-33. PubMed ID: 185057
    [Abstract] [Full Text] [Related]

  • 18. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA, Mayer AM, Pasqualini CD.
    Cancer Res; 1977 Jun 01; 37(6):1768-76. PubMed ID: 192461
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D, Parenti A, Biasi G, Chieco-Bianchi L, Colombatti A.
    J Natl Cancer Inst; 1978 Sep 01; 61(3):885-90. PubMed ID: 80457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.